Brian Schwartz

Brian brings more than a decade of experience as a drug development expert in pharmaceutical and biotechnology industries, spanning several therapeutic areas including oncology, dermatology, neurology and rare diseases. Served in senior leadership roles at ArQule, Ziopharm, Bayer and Leo Labs, accumulated a number of successful New Drug Applications (NDA), numerous Investigational New Drug (IND) applications, preclinical and clinical drug development programs. During his time in biotech,  he acquired knowledge of investor relations, partnering and capital raising. He is currently an advisor for California Institute of Regenerative Medicine, numerous biotech companies, and board member of LifeSci Acquisition Corp. Qualified as a medical doctor in South Africa followed by additional fellowship training in Canada.